Invenio Imaging

Executive Summary

Invenio Imaging is a Santa Clara-based medical device company developing the NIO Laser Imaging System, which uses Stimulated Raman Histology (SRH) to provide rapid, label-free intraoperative tissue imaging. The system delivers digital pathology images in under three minutes, enabling real-time decision-making during surgery and preserving tissue for downstream analysis. By streamlining surgical workflows and facilitating digital image sharing, Invenio aims to improve diagnostic accuracy and efficiency in oncology and other surgical fields. The company has positioned itself at the intersection of advanced imaging and digital pathology, addressing a critical need for speed and precision in intraoperative diagnostics. With its proprietary SRH technology, Invenio offers a label-free alternative to traditional frozen section analysis, potentially reducing surgery times and improving patient outcomes. As the adoption of digital pathology grows, Invenio’s platform is poised for expansion into new clinical indications and geographies.

Upcoming Catalysts (preview)

• Q3 2026FDA 510(k) clearance for expanded use in breast cancer surgery70% success
• Q2 2026Publication of real-world clinical data demonstrating improved sensitivity/specificity vs. frozen sections80% success
• Q4 2026Strategic partnership with a major medical device distributor for US commercialization60% success